Enovis to Buy eCential Robotics for €155M

Enovis has entered a binding offer to acquire eCential Robotics, a developer of enabling technologies and surgical robotics.

eCential Robotics boasts over 15 years of experience in computer-assisted surgery and orthopedic robotics. Its modular Op.n platform combines surgical navigation and active robotics and is U.S. Food and Drug Administration (FDA) 510(k)-cleared for spine surgery in the U.S. The acquisition adds robotics, software, and surgical automation capabilities to Enovis’ ASTRA technology ecosystem and supports its development roadmap.

Last week, eCential earned an FDA nod for Spineart’s PERLA TL application for use with the Op.n platform. The integration combines implant technology, real-time navigation, and robotic assistance to support implant placement accuracy and workflow efficiency in open and minimally invasive spine procedures.

Under the agreement’s terms, Enovis will buy eCential for an upfront enterprise value of €155 million. The transaction is anticipated to close by the end of the year.

Comments from Enovis and eCential Robotics

Damien McDonald, CEO, Enovis: “This acquisition is a significant milestone and reflects our disciplined approach to bringing externally developed innovation into Enovis. The eCential Robotics team brings exceptional engineering talent, intellectual property and a proven track record of bringing innovative robotic solutions to market. Their expertise will serve as the bedrock of our robotics strategy and enable Enovis to win in surgical enabling technology. eCential Robotics’ robotics platform is a natural complement to our ARVIS Augmented Reality System and will give surgeons a broader set of robotic solutions, aiming to improve precision, streamline workflows in the operating room and deliver better outcomes for patients.” 

Clément Vidal, CEO, eCential Robotics: “Our strategy at eCential Robotics has always been to offer surgeons easy-to-use, cutting-edge technology to improve surgical workflows, and ultimately, enable better patient outcomes. As part of Enovis, we will be able to grow through a shared mission to support surgeons with greater operating room efficiency, and help patients live more full, active lives. I am truly excited about the opportunities we will unlock together.”

Stéphane Lavallée, founder and chair, eCential Robotics: “I could not be more excited about the next chapter for eCential Robotics. Enovis brings focus, speed, and a real commitment to the future of eCential Robotics. Together, the combined companies will continue to support existing partnerships and build a center of excellence for robotics in Grenoble focused on advancing the shared innovation roadmap.”